Dr Mashal Al-Mutairi
Active and Inactive Ingredients in Pharmaceutical Formulation
Tuesday 21 Jan 2025
Medication Safety and Adverse Drug Events
Address challenges related to medication safety and adverse drug events (ADEs). Discuss strategies to prevent medication errors, reduce ADEs, and improve medication reconciliation processes through interdisciplinary collaboration and enhanced communication.
Wednesday 22 Jan 2025
Pharmacy Automation and Robotics
Explore the role of automation and robotics in pharmacy operations to enhance efficiency, accuracy, and patient safety. Discuss automated dispensing systems, robotic medication packaging, inventory management solutions, and workflow optimization strategies for modern pharmacy settings.
Wednesday 22 Jan 2025
Pharmacogenomics and Personalized Medicine
Explore the intersection of genetics and pharmacology to understand how individual genetic variations impact drug response. Discuss the applications of pharmacogenomics in tailoring medication regimens to individual patients, optimizing efficacy, and minimizing adverse effects.
Thursday 23 Jan 2025
Advancements in Pharmacotherapy
Explore the latest developments in pharmacotherapy, including novel drug formulations, targeted therapies, and personalized medicine approaches. Discover how these innovations are revolutionizing patient care and improving treatment outcomes across various disease areas.
Thursday 23 Jan 2025
Pharmaceutical Regulatory Affairs
Navigate the complex landscape of pharmaceutical regulations and compliance requirements. Gain insights into regulatory updates, drug approval processes, pharmacovigilance, and quality assurance practices to ensure adherence to global standards and regulatory guidelines.
Thursday 23 Jan 2025
Pharmaceutical Industry Trends
Stay abreast of emerging trends and market dynamics shaping the pharmaceutical industry. Analyze market access strategies, drug pricing policies, and market expansion opportunities in an era of evolving healthcare ecosystems and shifting consumer preferences.